nodes	percent_of_prediction	percent_of_DWPC	metapath
Sorafenib—MAPK15—brainstem—Behcet's disease	0.013	0.0188	CbGeAlD
Sorafenib—TIE1—endothelium—Behcet's disease	0.0119	0.0172	CbGeAlD
Sorafenib—TIE1—blood vessel—Behcet's disease	0.011	0.0159	CbGeAlD
Sorafenib—FLT4—endothelium—Behcet's disease	0.00983	0.0142	CbGeAlD
Sorafenib—MUSK—nervous system—Behcet's disease	0.00928	0.0134	CbGeAlD
Sorafenib—MAPK15—medulla oblongata—Behcet's disease	0.00907	0.0131	CbGeAlD
Sorafenib—FLT4—blood vessel—Behcet's disease	0.00907	0.0131	CbGeAlD
Sorafenib—FLT1—artery—Behcet's disease	0.00905	0.0131	CbGeAlD
Sorafenib—KDR—artery—Behcet's disease	0.00765	0.0111	CbGeAlD
Sorafenib—FLT1—endothelium—Behcet's disease	0.00764	0.011	CbGeAlD
Sorafenib—CDKL2—nervous system—Behcet's disease	0.00757	0.0109	CbGeAlD
Sorafenib—CDKL2—central nervous system—Behcet's disease	0.00729	0.0105	CbGeAlD
Sorafenib—FLT1—blood vessel—Behcet's disease	0.00705	0.0102	CbGeAlD
Sorafenib—MAPK15—nervous system—Behcet's disease	0.00681	0.00985	CbGeAlD
Sorafenib—MAPK15—central nervous system—Behcet's disease	0.00656	0.00948	CbGeAlD
Sorafenib—KDR—endothelium—Behcet's disease	0.00646	0.00934	CbGeAlD
Sorafenib—ZAK—eye—Behcet's disease	0.00638	0.00923	CbGeAlD
Sorafenib—CDKL3—brain—Behcet's disease	0.00632	0.00914	CbGeAlD
Sorafenib—HIPK3—retina—Behcet's disease	0.00619	0.00895	CbGeAlD
Sorafenib—KDR—blood vessel—Behcet's disease	0.00596	0.00861	CbGeAlD
Sorafenib—CDKL2—brain—Behcet's disease	0.00578	0.00836	CbGeAlD
Sorafenib—KIT—endothelium—Behcet's disease	0.00573	0.00828	CbGeAlD
Sorafenib—EPHX2—eye—Behcet's disease	0.00535	0.00773	CbGeAlD
Sorafenib—EPHX2—retina—Behcet's disease	0.0053	0.00766	CbGeAlD
Sorafenib—KIT—blood vessel—Behcet's disease	0.00528	0.00763	CbGeAlD
Sorafenib—MAPK15—brain—Behcet's disease	0.00521	0.00753	CbGeAlD
Sorafenib—PDGFRB—blood vessel—Behcet's disease	0.00516	0.00745	CbGeAlD
Sorafenib—ZAK—mammalian vulva—Behcet's disease	0.00507	0.00732	CbGeAlD
Sorafenib—FLT4—eye—Behcet's disease	0.00482	0.00697	CbGeAlD
Sorafenib—HIPK3—cardiac atrium—Behcet's disease	0.00475	0.00686	CbGeAlD
Sorafenib—MAP3K7—retina—Behcet's disease	0.00447	0.00645	CbGeAlD
Sorafenib—TIE1—cardiac atrium—Behcet's disease	0.00444	0.00641	CbGeAlD
Sorafenib—KIT—mouth—Behcet's disease	0.00442	0.00639	CbGeAlD
Sorafenib—MKNK2—eye—Behcet's disease	0.00437	0.00631	CbGeAlD
Sorafenib—MKNK2—retina—Behcet's disease	0.00433	0.00626	CbGeAlD
Sorafenib—MKNK1—eye—Behcet's disease	0.00431	0.00623	CbGeAlD
Sorafenib—MKNK1—retina—Behcet's disease	0.00427	0.00618	CbGeAlD
Sorafenib—EPHX2—mammalian vulva—Behcet's disease	0.00424	0.00614	CbGeAlD
Sorafenib—MAPK11—nervous system—Behcet's disease	0.00404	0.00584	CbGeAlD
Sorafenib—CDK7—nervous system—Behcet's disease	0.00398	0.00575	CbGeAlD
Sorafenib—RALBP1—eye—Behcet's disease	0.00394	0.0057	CbGeAlD
Sorafenib—AURKC—nervous system—Behcet's disease	0.00391	0.00566	CbGeAlD
Sorafenib—RALBP1—retina—Behcet's disease	0.00391	0.00565	CbGeAlD
Sorafenib—MAPK11—central nervous system—Behcet's disease	0.00389	0.00562	CbGeAlD
Sorafenib—RAF1—brainstem—Behcet's disease	0.00383	0.00554	CbGeAlD
Sorafenib—CDK7—central nervous system—Behcet's disease	0.00383	0.00553	CbGeAlD
Sorafenib—FGFR1—mammalian vulva—Behcet's disease	0.00378	0.00546	CbGeAlD
Sorafenib—AURKC—central nervous system—Behcet's disease	0.00377	0.00545	CbGeAlD
Sorafenib—FLT1—eye—Behcet's disease	0.00375	0.00542	CbGeAlD
Sorafenib—RAF1—eye—Behcet's disease	0.00373	0.00539	CbGeAlD
Sorafenib—FLT1—retina—Behcet's disease	0.00372	0.00537	CbGeAlD
Sorafenib—BRAF—midbrain—Behcet's disease	0.00366	0.0053	CbGeAlD
Sorafenib—EPHA6—nervous system—Behcet's disease	0.00362	0.00524	CbGeAlD
Sorafenib—FGFR1—cardiac atrium—Behcet's disease	0.00362	0.00523	CbGeAlD
Sorafenib—MAP3K7—mammalian vulva—Behcet's disease	0.00358	0.00517	CbGeAlD
Sorafenib—HIPK4—brain—Behcet's disease	0.0035	0.00507	CbGeAlD
Sorafenib—EPHA6—central nervous system—Behcet's disease	0.00349	0.00504	CbGeAlD
Sorafenib—MKNK2—mammalian vulva—Behcet's disease	0.00347	0.00501	CbGeAlD
Sorafenib—ZAK—nervous system—Behcet's disease	0.00344	0.00497	CbGeAlD
Sorafenib—MAP3K7—cardiac atrium—Behcet's disease	0.00342	0.00495	CbGeAlD
Sorafenib—MKNK1—mammalian vulva—Behcet's disease	0.00342	0.00495	CbGeAlD
Sorafenib—FGFR1—medulla oblongata—Behcet's disease	0.00341	0.00493	CbGeAlD
Sorafenib—MKNK2—cardiac atrium—Behcet's disease	0.00332	0.0048	CbGeAlD
Sorafenib—ZAK—central nervous system—Behcet's disease	0.00331	0.00478	CbGeAlD
Sorafenib—MAP3K19—nervous system—Behcet's disease	0.00329	0.00476	CbGeAlD
Sorafenib—MKNK1—cardiac atrium—Behcet's disease	0.00328	0.00474	CbGeAlD
Sorafenib—MAP2K5—brainstem—Behcet's disease	0.00326	0.00471	CbGeAlD
Sorafenib—RAF1—skin of body—Behcet's disease	0.00324	0.00469	CbGeAlD
Sorafenib—MAP3K7—medulla oblongata—Behcet's disease	0.00323	0.00467	CbGeAlD
Sorafenib—EPHB6—skin of body—Behcet's disease	0.00323	0.00466	CbGeAlD
Sorafenib—MAP3K19—central nervous system—Behcet's disease	0.00317	0.00458	CbGeAlD
Sorafenib—KDR—eye—Behcet's disease	0.00317	0.00458	CbGeAlD
Sorafenib—KDR—retina—Behcet's disease	0.00314	0.00454	CbGeAlD
Sorafenib—TIE1—nervous system—Behcet's disease	0.00314	0.00454	CbGeAlD
Sorafenib—RALBP1—mammalian vulva—Behcet's disease	0.00313	0.00452	CbGeAlD
Sorafenib—MKNK2—medulla oblongata—Behcet's disease	0.00313	0.00452	CbGeAlD
Sorafenib—FGFR1—midbrain—Behcet's disease	0.00312	0.0045	CbGeAlD
Sorafenib—CSF1R—eye—Behcet's disease	0.00309	0.00447	CbGeAlD
Sorafenib—MKNK1—medulla oblongata—Behcet's disease	0.00309	0.00446	CbGeAlD
Sorafenib—MAPK11—brain—Behcet's disease	0.00309	0.00446	CbGeAlD
Sorafenib—RET—medulla oblongata—Behcet's disease	0.00305	0.00441	CbGeAlD
Sorafenib—FGFR1—spinal cord—Behcet's disease	0.00304	0.00439	CbGeAlD
Sorafenib—CDK7—brain—Behcet's disease	0.00304	0.00439	CbGeAlD
Sorafenib—TIE1—central nervous system—Behcet's disease	0.00303	0.00437	CbGeAlD
Sorafenib—TAOK2—brain—Behcet's disease	0.00301	0.00436	CbGeAlD
Sorafenib—RALBP1—cardiac atrium—Behcet's disease	0.003	0.00433	CbGeAlD
Sorafenib—AURKC—brain—Behcet's disease	0.00299	0.00432	CbGeAlD
Sorafenib—FLT1—mammalian vulva—Behcet's disease	0.00298	0.0043	CbGeAlD
Sorafenib—RAF1—mammalian vulva—Behcet's disease	0.00296	0.00428	CbGeAlD
Sorafenib—MAP3K7—midbrain—Behcet's disease	0.00295	0.00426	CbGeAlD
Sorafenib—EPHB6—mammalian vulva—Behcet's disease	0.00294	0.00425	CbGeAlD
Sorafenib—KIT—brainstem—Behcet's disease	0.00289	0.00417	CbGeAlD
Sorafenib—MAP3K7—spinal cord—Behcet's disease	0.00288	0.00416	CbGeAlD
Sorafenib—MKNK2—midbrain—Behcet's disease	0.00286	0.00413	CbGeAlD
Sorafenib—FLT1—cardiac atrium—Behcet's disease	0.00285	0.00412	CbGeAlD
Sorafenib—RAF1—cardiac atrium—Behcet's disease	0.00283	0.0041	CbGeAlD
Sorafenib—RALBP1—medulla oblongata—Behcet's disease	0.00282	0.00408	CbGeAlD
Sorafenib—MKNK1—midbrain—Behcet's disease	0.00282	0.00408	CbGeAlD
Sorafenib—STK10—mammalian vulva—Behcet's disease	0.00282	0.00407	CbGeAlD
Sorafenib—EPHB6—cardiac atrium—Behcet's disease	0.00282	0.00407	CbGeAlD
Sorafenib—MKNK2—spinal cord—Behcet's disease	0.00279	0.00403	CbGeAlD
Sorafenib—RET—midbrain—Behcet's disease	0.00279	0.00403	CbGeAlD
Sorafenib—EPHA6—brain—Behcet's disease	0.00277	0.004	CbGeAlD
Sorafenib—MKNK1—spinal cord—Behcet's disease	0.00275	0.00398	CbGeAlD
Sorafenib—PDGFRB—eye—Behcet's disease	0.00274	0.00397	CbGeAlD
Sorafenib—RET—spinal cord—Behcet's disease	0.00272	0.00393	CbGeAlD
Sorafenib—CSF1R—skin of body—Behcet's disease	0.00269	0.00389	CbGeAlD
Sorafenib—FLT1—medulla oblongata—Behcet's disease	0.00269	0.00388	CbGeAlD
Sorafenib—RAF1—medulla oblongata—Behcet's disease	0.00267	0.00386	CbGeAlD
Sorafenib—EPHB6—medulla oblongata—Behcet's disease	0.00266	0.00384	CbGeAlD
Sorafenib—ZAK—brain—Behcet's disease	0.00263	0.0038	CbGeAlD
Sorafenib—RALBP1—midbrain—Behcet's disease	0.00258	0.00373	CbGeAlD
Sorafenib—HIPK3—brain—Behcet's disease	0.00257	0.00371	CbGeAlD
Sorafenib—RALBP1—spinal cord—Behcet's disease	0.00252	0.00364	CbGeAlD
Sorafenib—MAP3K19—brain—Behcet's disease	0.00252	0.00364	CbGeAlD
Sorafenib—KDR—mammalian vulva—Behcet's disease	0.00252	0.00364	CbGeAlD
Sorafenib—MAP2K5—mammalian vulva—Behcet's disease	0.00252	0.00364	CbGeAlD
Sorafenib—FLT1—midbrain—Behcet's disease	0.00246	0.00355	CbGeAlD
Sorafenib—CSF1R—mammalian vulva—Behcet's disease	0.00246	0.00355	CbGeAlD
Sorafenib—KIT—skin of body—Behcet's disease	0.00244	0.00353	CbGeAlD
Sorafenib—RAF1—midbrain—Behcet's disease	0.00244	0.00353	CbGeAlD
Sorafenib—EPHB6—midbrain—Behcet's disease	0.00243	0.00351	CbGeAlD
Sorafenib—KDR—cardiac atrium—Behcet's disease	0.00241	0.00348	CbGeAlD
Sorafenib—MAP2K5—cardiac atrium—Behcet's disease	0.00241	0.00348	CbGeAlD
Sorafenib—TIE1—brain—Behcet's disease	0.0024	0.00347	CbGeAlD
Sorafenib—FLT1—spinal cord—Behcet's disease	0.0024	0.00346	CbGeAlD
Sorafenib—PDGFRB—skin of body—Behcet's disease	0.00239	0.00345	CbGeAlD
Sorafenib—RAF1—spinal cord—Behcet's disease	0.00238	0.00344	CbGeAlD
Sorafenib—HTR2C—brainstem—Behcet's disease	0.00238	0.00344	CbGeAlD
Sorafenib—EPHB6—spinal cord—Behcet's disease	0.00237	0.00342	CbGeAlD
Sorafenib—CSF1R—cardiac atrium—Behcet's disease	0.00235	0.0034	CbGeAlD
Sorafenib—MKNK2—nervous system—Behcet's disease	0.00235	0.0034	CbGeAlD
Sorafenib—MKNK1—nervous system—Behcet's disease	0.00232	0.00335	CbGeAlD
Sorafenib—BRAF—brain—Behcet's disease	0.0023	0.00333	CbGeAlD
Sorafenib—RET—nervous system—Behcet's disease	0.00229	0.00331	CbGeAlD
Sorafenib—MAP2K5—medulla oblongata—Behcet's disease	0.00227	0.00328	CbGeAlD
Sorafenib—KDR—medulla oblongata—Behcet's disease	0.00227	0.00328	CbGeAlD
Sorafenib—MKNK2—central nervous system—Behcet's disease	0.00226	0.00327	CbGeAlD
Sorafenib—PDGFRA—spinal cord—Behcet's disease	0.00225	0.00325	CbGeAlD
Sorafenib—MKNK1—central nervous system—Behcet's disease	0.00223	0.00323	CbGeAlD
Sorafenib—KIT—mammalian vulva—Behcet's disease	0.00223	0.00322	CbGeAlD
Sorafenib—CSF1R—medulla oblongata—Behcet's disease	0.00222	0.0032	CbGeAlD
Sorafenib—RET—central nervous system—Behcet's disease	0.00221	0.00319	CbGeAlD
Sorafenib—EPHX2—brain—Behcet's disease	0.0022	0.00318	CbGeAlD
Sorafenib—PDGFRB—mammalian vulva—Behcet's disease	0.00218	0.00315	CbGeAlD
Sorafenib—RALBP1—nervous system—Behcet's disease	0.00212	0.00307	CbGeAlD
Sorafenib—PDGFRB—cardiac atrium—Behcet's disease	0.00209	0.00301	CbGeAlD
Sorafenib—KDR—midbrain—Behcet's disease	0.00208	0.003	CbGeAlD
Sorafenib—MAP2K5—midbrain—Behcet's disease	0.00208	0.003	CbGeAlD
Sorafenib—RALBP1—central nervous system—Behcet's disease	0.00204	0.00295	CbGeAlD
Sorafenib—CSF1R—midbrain—Behcet's disease	0.00203	0.00293	CbGeAlD
Sorafenib—KDR—spinal cord—Behcet's disease	0.00203	0.00293	CbGeAlD
Sorafenib—MAP2K5—spinal cord—Behcet's disease	0.00203	0.00293	CbGeAlD
Sorafenib—FLT1—nervous system—Behcet's disease	0.00202	0.00292	CbGeAlD
Sorafenib—KIT—medulla oblongata—Behcet's disease	0.00201	0.00291	CbGeAlD
Sorafenib—RAF1—nervous system—Behcet's disease	0.00201	0.0029	CbGeAlD
Sorafenib—EPHB6—nervous system—Behcet's disease	0.002	0.00288	CbGeAlD
Sorafenib—FLT4—brain—Behcet's disease	0.00198	0.00287	CbGeAlD
Sorafenib—CSF1R—spinal cord—Behcet's disease	0.00198	0.00286	CbGeAlD
Sorafenib—PDGFRB—medulla oblongata—Behcet's disease	0.00197	0.00284	CbGeAlD
Sorafenib—FGFR1—brain—Behcet's disease	0.00196	0.00283	CbGeAlD
Sorafenib—FLT1—central nervous system—Behcet's disease	0.00194	0.00281	CbGeAlD
Sorafenib—RAF1—central nervous system—Behcet's disease	0.00193	0.00279	CbGeAlD
Sorafenib—EPHB6—central nervous system—Behcet's disease	0.00192	0.00278	CbGeAlD
Sorafenib—STK10—nervous system—Behcet's disease	0.00191	0.00276	CbGeAlD
Sorafenib—PDGFRA—nervous system—Behcet's disease	0.00189	0.00273	CbGeAlD
Sorafenib—HTR2B—skin of body—Behcet's disease	0.00189	0.00273	CbGeAlD
Sorafenib—MAP3K7—brain—Behcet's disease	0.00185	0.00268	CbGeAlD
Sorafenib—STK10—central nervous system—Behcet's disease	0.00184	0.00266	CbGeAlD
Sorafenib—KIT—midbrain—Behcet's disease	0.00184	0.00266	CbGeAlD
Sorafenib—PDGFRA—central nervous system—Behcet's disease	0.00182	0.00263	CbGeAlD
Sorafenib—PDGFRB—midbrain—Behcet's disease	0.0018	0.0026	CbGeAlD
Sorafenib—MKNK2—brain—Behcet's disease	0.0018	0.0026	CbGeAlD
Sorafenib—KIT—spinal cord—Behcet's disease	0.00179	0.00259	CbGeAlD
Sorafenib—MKNK1—brain—Behcet's disease	0.00177	0.00256	CbGeAlD
Sorafenib—PDGFRB—spinal cord—Behcet's disease	0.00175	0.00253	CbGeAlD
Sorafenib—RET—brain—Behcet's disease	0.00175	0.00253	CbGeAlD
Sorafenib—MAP2K5—nervous system—Behcet's disease	0.00171	0.00247	CbGeAlD
Sorafenib—KDR—nervous system—Behcet's disease	0.00171	0.00247	CbGeAlD
Sorafenib—CSF1R—nervous system—Behcet's disease	0.00167	0.00241	CbGeAlD
Sorafenib—HTR2C—medulla oblongata—Behcet's disease	0.00166	0.0024	CbGeAlD
Sorafenib—KDR—central nervous system—Behcet's disease	0.00164	0.00237	CbGeAlD
Sorafenib—MAP2K5—central nervous system—Behcet's disease	0.00164	0.00237	CbGeAlD
Sorafenib—RALBP1—brain—Behcet's disease	0.00162	0.00234	CbGeAlD
Sorafenib—CSF1R—central nervous system—Behcet's disease	0.0016	0.00232	CbGeAlD
Sorafenib—FLT1—brain—Behcet's disease	0.00154	0.00223	CbGeAlD
Sorafenib—RAF1—brain—Behcet's disease	0.00153	0.00222	CbGeAlD
Sorafenib—EPHB6—brain—Behcet's disease	0.00153	0.0022	CbGeAlD
Sorafenib—HTR2C—midbrain—Behcet's disease	0.00152	0.00219	CbGeAlD
Sorafenib—KIT—nervous system—Behcet's disease	0.00151	0.00219	CbGeAlD
Sorafenib—HTR2C—spinal cord—Behcet's disease	0.00148	0.00214	CbGeAlD
Sorafenib—PDGFRB—nervous system—Behcet's disease	0.00148	0.00214	CbGeAlD
Sorafenib—STK10—brain—Behcet's disease	0.00146	0.00211	CbGeAlD
Sorafenib—KIT—central nervous system—Behcet's disease	0.00146	0.0021	CbGeAlD
Sorafenib—PDGFRA—brain—Behcet's disease	0.00145	0.00209	CbGeAlD
Sorafenib—ABCB1—blood vessel—Behcet's disease	0.00143	0.00207	CbGeAlD
Sorafenib—PDGFRB—central nervous system—Behcet's disease	0.00142	0.00206	CbGeAlD
Sorafenib—MAP2K5—brain—Behcet's disease	0.0013	0.00189	CbGeAlD
Sorafenib—KDR—brain—Behcet's disease	0.0013	0.00189	CbGeAlD
Sorafenib—CSF1R—brain—Behcet's disease	0.00127	0.00184	CbGeAlD
Sorafenib—HTR2C—nervous system—Behcet's disease	0.00125	0.0018	CbGeAlD
Sorafenib—CYP2B6—skin of body—Behcet's disease	0.00124	0.00179	CbGeAlD
Sorafenib—ABCG2—mammalian vulva—Behcet's disease	0.00122	0.00177	CbGeAlD
Sorafenib—HTR2C—central nervous system—Behcet's disease	0.0012	0.00173	CbGeAlD
Sorafenib—ABCC4—nervous system—Behcet's disease	0.00118	0.0017	CbGeAlD
Sorafenib—HTR2B—nervous system—Behcet's disease	0.00117	0.00169	CbGeAlD
Sorafenib—KIT—brain—Behcet's disease	0.00116	0.00167	CbGeAlD
Sorafenib—ABCC4—central nervous system—Behcet's disease	0.00113	0.00164	CbGeAlD
Sorafenib—PDGFRB—brain—Behcet's disease	0.00113	0.00163	CbGeAlD
Sorafenib—HTR2B—central nervous system—Behcet's disease	0.00113	0.00163	CbGeAlD
Sorafenib—ABCG2—medulla oblongata—Behcet's disease	0.00111	0.0016	CbGeAlD
Sorafenib—CYP2D6—brainstem—Behcet's disease	0.00109	0.00157	CbGeAlD
Sorafenib—ABCG2—midbrain—Behcet's disease	0.00101	0.00146	CbGeAlD
Sorafenib—ABCG2—spinal cord—Behcet's disease	0.000985	0.00142	CbGeAlD
Sorafenib—HTR2C—brain—Behcet's disease	0.000952	0.00138	CbGeAlD
Sorafenib—ABCC4—brain—Behcet's disease	0.000899	0.0013	CbGeAlD
Sorafenib—HTR2B—brain—Behcet's disease	0.000894	0.00129	CbGeAlD
Sorafenib—CYP2B6—nervous system—Behcet's disease	0.000766	0.00111	CbGeAlD
Sorafenib—ABCB1—retina—Behcet's disease	0.000754	0.00109	CbGeAlD
Sorafenib—CYP2B6—central nervous system—Behcet's disease	0.000737	0.00107	CbGeAlD
Sorafenib—CYP2C8—brain—Behcet's disease	0.000653	0.000943	CbGeAlD
Sorafenib—ABCG2—brain—Behcet's disease	0.000635	0.000917	CbGeAlD
Sorafenib—ABCB1—mammalian vulva—Behcet's disease	0.000604	0.000872	CbGeAlD
Sorafenib—CYP2B6—brain—Behcet's disease	0.000585	0.000846	CbGeAlD
Sorafenib—CYP3A4—nervous system—Behcet's disease	0.000578	0.000836	CbGeAlD
Sorafenib—CYP2D6—nervous system—Behcet's disease	0.000569	0.000823	CbGeAlD
Sorafenib—CYP3A4—central nervous system—Behcet's disease	0.000557	0.000805	CbGeAlD
Sorafenib—CYP2D6—central nervous system—Behcet's disease	0.000548	0.000792	CbGeAlD
Sorafenib—ABCB1—medulla oblongata—Behcet's disease	0.000545	0.000788	CbGeAlD
Sorafenib—ABCB1—midbrain—Behcet's disease	0.000498	0.00072	CbGeAlD
Sorafenib—ABCB1—spinal cord—Behcet's disease	0.000486	0.000702	CbGeAlD
Sorafenib—CYP2D6—brain—Behcet's disease	0.000435	0.000629	CbGeAlD
Sorafenib—ABCB1—nervous system—Behcet's disease	0.000409	0.000592	CbGeAlD
Sorafenib—ABCB1—central nervous system—Behcet's disease	0.000394	0.00057	CbGeAlD
Sorafenib—ABCB1—brain—Behcet's disease	0.000313	0.000452	CbGeAlD
Sorafenib—FGFR1—Adaptive Immune System—HLA-B—Behcet's disease	0.000237	0.00077	CbGpPWpGaD
Sorafenib—PDGFRA—Adaptive Immune System—HLA-B—Behcet's disease	0.000237	0.000768	CbGpPWpGaD
Sorafenib—EPHA6—Developmental Biology—TNF—Behcet's disease	0.000234	0.000759	CbGpPWpGaD
Sorafenib—CDK7—Disease—APOB—Behcet's disease	0.000229	0.000744	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—APOB—Behcet's disease	0.000228	0.00074	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—CTLA4—Behcet's disease	0.000227	0.000737	CbGpPWpGaD
Sorafenib—RAF1—Immune System—ITGAL—Behcet's disease	0.000226	0.000734	CbGpPWpGaD
Sorafenib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Behcet's disease	0.000225	0.000731	CbGpPWpGaD
Sorafenib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Behcet's disease	0.000225	0.000731	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—CCR1—Behcet's disease	0.000224	0.000728	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—CCR1—Behcet's disease	0.000224	0.000728	CbGpPWpGaD
Sorafenib—ABCC4—Hemostasis—APOA1—Behcet's disease	0.000223	0.000725	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.000222	0.000721	CbGpPWpGaD
Sorafenib—PDGFRB—Innate Immune System—HLA-B—Behcet's disease	0.000222	0.00072	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—APOA1—Behcet's disease	0.000221	0.000718	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—APOA1—Behcet's disease	0.000218	0.000706	CbGpPWpGaD
Sorafenib—PDGFRB—Adaptive Immune System—HLA-B—Behcet's disease	0.000213	0.000691	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—CCR1—Behcet's disease	0.000213	0.000691	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—CCR1—Behcet's disease	0.000212	0.000689	CbGpPWpGaD
Sorafenib—RAF1—MAPK Signaling Pathway—TNF—Behcet's disease	0.000212	0.000689	CbGpPWpGaD
Sorafenib—ABCC2—Transmembrane transport of small molecules—APOB—Behcet's disease	0.000206	0.000669	CbGpPWpGaD
Sorafenib—RAF1—Transmembrane transport of small molecules—APOB—Behcet's disease	0.000206	0.000667	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—APOB—Behcet's disease	0.000205	0.000666	CbGpPWpGaD
Sorafenib—KIT—Immune System—CTLA4—Behcet's disease	0.000205	0.000665	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—CTLA4—Behcet's disease	0.000205	0.000665	CbGpPWpGaD
Sorafenib—MKNK1—Disease—SERPINE1—Behcet's disease	0.000204	0.000664	CbGpPWpGaD
Sorafenib—KIT—Adaptive Immune System—ICAM1—Behcet's disease	0.000203	0.000659	CbGpPWpGaD
Sorafenib—MAP3K7—Adaptive Immune System—ICAM1—Behcet's disease	0.000203	0.000659	CbGpPWpGaD
Sorafenib—EPHX2—Metabolism—NOS3—Behcet's disease	0.000201	0.000651	CbGpPWpGaD
Sorafenib—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	0.000198	0.000644	CbGpPWpGaD
Sorafenib—RAF1—Innate Immune System—HLA-B—Behcet's disease	0.000198	0.000642	CbGpPWpGaD
Sorafenib—MKNK1—Disease—NOS3—Behcet's disease	0.000195	0.000633	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—CTLA4—Behcet's disease	0.000194	0.000631	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—CTLA4—Behcet's disease	0.000194	0.000629	CbGpPWpGaD
Sorafenib—ABCC4—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.000193	0.000628	CbGpPWpGaD
Sorafenib—FGFR1—Adaptive Immune System—ICAM1—Behcet's disease	0.000193	0.000625	CbGpPWpGaD
Sorafenib—PDGFRA—Adaptive Immune System—ICAM1—Behcet's disease	0.000192	0.000624	CbGpPWpGaD
Sorafenib—RAF1—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	0.000192	0.000622	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—CCR1—Behcet's disease	0.000191	0.000621	CbGpPWpGaD
Sorafenib—RAF1—Adaptive Immune System—HLA-B—Behcet's disease	0.00019	0.000616	CbGpPWpGaD
Sorafenib—RAF1—Hemostasis—APOA1—Behcet's disease	0.000188	0.00061	CbGpPWpGaD
Sorafenib—ABCB1—Allograft Rejection—TNF—Behcet's disease	0.000183	0.000594	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—CCR1—Behcet's disease	0.000182	0.000592	CbGpPWpGaD
Sorafenib—CDK7—Disease—APOA1—Behcet's disease	0.000181	0.000589	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—APOA1—Behcet's disease	0.00018	0.000585	CbGpPWpGaD
Sorafenib—ABCG2—Transmembrane transport of small molecules—APOB—Behcet's disease	0.000179	0.000582	CbGpPWpGaD
Sorafenib—ABCC4—Hemostasis—SERPINE1—Behcet's disease	0.000177	0.000576	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	0.000176	0.000571	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—SERPINE1—Behcet's disease	0.000176	0.00057	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—CTLA4—Behcet's disease	0.000175	0.000567	CbGpPWpGaD
Sorafenib—PDGFRB—Adaptive Immune System—ICAM1—Behcet's disease	0.000173	0.000562	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—SERPINE1—Behcet's disease	0.000173	0.000561	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—CCR1—Behcet's disease	0.000171	0.000553	CbGpPWpGaD
Sorafenib—ABCC4—Hemostasis—NOS3—Behcet's disease	0.000169	0.000549	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—HLA-B—Behcet's disease	0.000168	0.000545	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—NOS3—Behcet's disease	0.000168	0.000544	CbGpPWpGaD
Sorafenib—BRAF—Disease—APOB—Behcet's disease	0.000166	0.000539	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—NOS3—Behcet's disease	0.000165	0.000535	CbGpPWpGaD
Sorafenib—ABCC2—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.000163	0.000529	CbGpPWpGaD
Sorafenib—RAF1—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.000163	0.000528	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—APOA1—Behcet's disease	0.000162	0.000527	CbGpPWpGaD
Sorafenib—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—Behcet's disease	0.00016	0.000519	CbGpPWpGaD
Sorafenib—RAF1—Immune System—CTLA4—Behcet's disease	0.000156	0.000505	CbGpPWpGaD
Sorafenib—CDK7—Gene Expression—SERPINE1—Behcet's disease	0.000155	0.000503	CbGpPWpGaD
Sorafenib—RAF1—Adaptive Immune System—ICAM1—Behcet's disease	0.000154	0.000501	CbGpPWpGaD
Sorafenib—KDR—Developmental Biology—TNF—Behcet's disease	0.000152	0.000493	CbGpPWpGaD
Sorafenib—KIT—Immune System—HLA-B—Behcet's disease	0.000152	0.000492	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—HLA-B—Behcet's disease	0.000152	0.000492	CbGpPWpGaD
Sorafenib—KIT—Disease—APOB—Behcet's disease	0.000151	0.000491	CbGpPWpGaD
Sorafenib—HTR2B—GPCR ligand binding—CXCL8—Behcet's disease	0.000151	0.00049	CbGpPWpGaD
Sorafenib—RAF1—Hemostasis—SERPINE1—Behcet's disease	0.000149	0.000484	CbGpPWpGaD
Sorafenib—RALBP1—Signaling Pathways—CXCL8—Behcet's disease	0.000149	0.000483	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—CCR1—Behcet's disease	0.000147	0.000478	CbGpPWpGaD
Sorafenib—FLT4—Signaling Pathways—CXCL8—Behcet's disease	0.000146	0.000475	CbGpPWpGaD
Sorafenib—CDK7—Disease—SERPINE1—Behcet's disease	0.000144	0.000467	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—HLA-B—Behcet's disease	0.000144	0.000467	CbGpPWpGaD
Sorafenib—FGFR1—Disease—APOB—Behcet's disease	0.000144	0.000466	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—HLA-B—Behcet's disease	0.000143	0.000466	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—SERPINE1—Behcet's disease	0.000143	0.000465	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—APOB—Behcet's disease	0.000143	0.000465	CbGpPWpGaD
Sorafenib—RAF1—Hemostasis—NOS3—Behcet's disease	0.000142	0.000462	CbGpPWpGaD
Sorafenib—ABCG2—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.000142	0.00046	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—APOB—Behcet's disease	0.00014	0.000455	CbGpPWpGaD
Sorafenib—CDK7—Disease—NOS3—Behcet's disease	0.000138	0.000446	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—NOS3—Behcet's disease	0.000137	0.000444	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—APOB—Behcet's disease	0.000137	0.000443	CbGpPWpGaD
Sorafenib—MAPK11—Immune System—ICAM1—Behcet's disease	0.000137	0.000443	CbGpPWpGaD
Sorafenib—BRAF—Disease—APOA1—Behcet's disease	0.000131	0.000427	CbGpPWpGaD
Sorafenib—MAPK11—Developmental Biology—TNF—Behcet's disease	0.000131	0.000424	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—HLA-B—Behcet's disease	0.000129	0.000419	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—APOB—Behcet's disease	0.000129	0.000419	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—SERPINE1—Behcet's disease	0.000129	0.000418	CbGpPWpGaD
Sorafenib—MAP3K7—Immune System—ICAM1—Behcet's disease	0.000123	0.0004	CbGpPWpGaD
Sorafenib—KIT—Immune System—ICAM1—Behcet's disease	0.000123	0.0004	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—NOS3—Behcet's disease	0.000123	0.000399	CbGpPWpGaD
Sorafenib—HTR2C—GPCR ligand binding—CXCL8—Behcet's disease	0.000122	0.000396	CbGpPWpGaD
Sorafenib—MKNK1—Signaling Pathways—CXCL8—Behcet's disease	0.000121	0.000393	CbGpPWpGaD
Sorafenib—KIT—Disease—APOA1—Behcet's disease	0.00012	0.000388	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—APOB—Behcet's disease	0.000117	0.000381	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.000117	0.00038	CbGpPWpGaD
Sorafenib—FGFR1—Immune System—ICAM1—Behcet's disease	0.000117	0.000379	CbGpPWpGaD
Sorafenib—PDGFRA—Immune System—ICAM1—Behcet's disease	0.000117	0.000378	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—APOB—Behcet's disease	0.000116	0.000378	CbGpPWpGaD
Sorafenib—RAF1—Immune System—HLA-B—Behcet's disease	0.000115	0.000374	CbGpPWpGaD
Sorafenib—RAF1—Disease—APOB—Behcet's disease	0.000115	0.000373	CbGpPWpGaD
Sorafenib—FGFR1—Disease—APOA1—Behcet's disease	0.000114	0.000368	CbGpPWpGaD
Sorafenib—MAPK11—Gene Expression—SERPINE1—Behcet's disease	0.000113	0.000368	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—APOA1—Behcet's disease	0.000113	0.000368	CbGpPWpGaD
Sorafenib—FGFR1—Developmental Biology—TNF—Behcet's disease	0.000112	0.000363	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—APOA1—Behcet's disease	0.000111	0.00036	CbGpPWpGaD
Sorafenib—FLT1—Signaling Pathways—CXCL8—Behcet's disease	0.000109	0.000354	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—APOA1—Behcet's disease	0.000108	0.000351	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—APOB—Behcet's disease	0.000106	0.000344	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—APOB—Behcet's disease	0.000106	0.000344	CbGpPWpGaD
Sorafenib—PDGFRB—Immune System—ICAM1—Behcet's disease	0.000105	0.000341	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.000104	0.000339	CbGpPWpGaD
Sorafenib—BRAF—Disease—SERPINE1—Behcet's disease	0.000104	0.000339	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—APOA1—Behcet's disease	0.000102	0.000331	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—CAT—Behcet's disease	0.000102	0.000331	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—CAT—Behcet's disease	0.000102	0.000331	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—APOB—Behcet's disease	0.0001	0.000326	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—APOB—Behcet's disease	0.0001	0.000325	CbGpPWpGaD
Sorafenib—BRAF—Disease—NOS3—Behcet's disease	9.96e-05	0.000323	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—APOB—Behcet's disease	9.9e-05	0.000321	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—APOB—Behcet's disease	9.9e-05	0.000321	CbGpPWpGaD
Sorafenib—ABCB1—Transmembrane transport of small molecules—APOB—Behcet's disease	9.69e-05	0.000315	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	9.52e-05	0.000309	CbGpPWpGaD
Sorafenib—KIT—Disease—SERPINE1—Behcet's disease	9.5e-05	0.000308	CbGpPWpGaD
Sorafenib—RAF1—Immune System—ICAM1—Behcet's disease	9.36e-05	0.000304	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—APOA1—Behcet's disease	9.29e-05	0.000302	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	9.26e-05	0.0003	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—APOA1—Behcet's disease	9.2e-05	0.000299	CbGpPWpGaD
Sorafenib—RAF1—Disease—APOA1—Behcet's disease	9.09e-05	0.000295	CbGpPWpGaD
Sorafenib—KIT—Disease—NOS3—Behcet's disease	9.07e-05	0.000294	CbGpPWpGaD
Sorafenib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	9.04e-05	0.000293	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—APOB—Behcet's disease	9.03e-05	0.000293	CbGpPWpGaD
Sorafenib—FGFR1—Disease—SERPINE1—Behcet's disease	9.01e-05	0.000293	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—SERPINE1—Behcet's disease	8.99e-05	0.000292	CbGpPWpGaD
Sorafenib—RAF1—Developmental Biology—TNF—Behcet's disease	8.96e-05	0.000291	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—SERPINE1—Behcet's disease	8.8e-05	0.000286	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—CAT—Behcet's disease	8.65e-05	0.000281	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—APOB—Behcet's disease	8.61e-05	0.000279	CbGpPWpGaD
Sorafenib—FGFR1—Disease—NOS3—Behcet's disease	8.61e-05	0.000279	CbGpPWpGaD
Sorafenib—PDGFRA—Disease—NOS3—Behcet's disease	8.58e-05	0.000279	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—SERPINE1—Behcet's disease	8.58e-05	0.000278	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—CAT—Behcet's disease	8.57e-05	0.000278	CbGpPWpGaD
Sorafenib—HTR2B—GPCR downstream signaling—CXCL8—Behcet's disease	8.54e-05	0.000277	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—NOS3—Behcet's disease	8.4e-05	0.000273	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—APOB—Behcet's disease	8.4e-05	0.000272	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—APOA1—Behcet's disease	8.38e-05	0.000272	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—APOA1—Behcet's disease	8.38e-05	0.000272	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—APOB—Behcet's disease	8.32e-05	0.00027	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	8.26e-05	0.000268	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—NOS3—Behcet's disease	8.19e-05	0.000266	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	8.14e-05	0.000264	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—SERPINE1—Behcet's disease	8.1e-05	0.000263	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—APOB—Behcet's disease	8.05e-05	0.000261	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—APOA1—Behcet's disease	7.95e-05	0.000258	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—APOA1—Behcet's disease	7.93e-05	0.000257	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—APOA1—Behcet's disease	7.83e-05	0.000254	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—APOA1—Behcet's disease	7.83e-05	0.000254	CbGpPWpGaD
Sorafenib—HTR2B—Signaling by GPCR—CXCL8—Behcet's disease	7.75e-05	0.000252	CbGpPWpGaD
Sorafenib—PDGFRB—Disease—NOS3—Behcet's disease	7.73e-05	0.000251	CbGpPWpGaD
Sorafenib—ABCB1—Transmembrane transport of small molecules—APOA1—Behcet's disease	7.67e-05	0.000249	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	7.53e-05	0.000244	CbGpPWpGaD
Sorafenib—MAP2K5—Signaling Pathways—CXCL8—Behcet's disease	7.45e-05	0.000242	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—SERPINE1—Behcet's disease	7.38e-05	0.000239	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—SERPINE1—Behcet's disease	7.31e-05	0.000237	CbGpPWpGaD
Sorafenib—KDR—Signaling Pathways—CXCL8—Behcet's disease	7.26e-05	0.000236	CbGpPWpGaD
Sorafenib—RAF1—Signaling by GPCR—CXCL8—Behcet's disease	7.25e-05	0.000235	CbGpPWpGaD
Sorafenib—RAF1—Disease—SERPINE1—Behcet's disease	7.22e-05	0.000234	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—APOA1—Behcet's disease	7.14e-05	0.000232	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—NOS3—Behcet's disease	7.04e-05	0.000229	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—NOS3—Behcet's disease	6.98e-05	0.000226	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—APOB—Behcet's disease	6.95e-05	0.000225	CbGpPWpGaD
Sorafenib—RAF1—Disease—NOS3—Behcet's disease	6.89e-05	0.000224	CbGpPWpGaD
Sorafenib—HTR2C—GPCR downstream signaling—CXCL8—Behcet's disease	6.89e-05	0.000224	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—APOA1—Behcet's disease	6.81e-05	0.000221	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—SERPINE1—Behcet's disease	6.65e-05	0.000216	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—SERPINE1—Behcet's disease	6.65e-05	0.000216	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—APOA1—Behcet's disease	6.64e-05	0.000216	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—APOA1—Behcet's disease	6.58e-05	0.000214	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	6.44e-05	0.000209	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—APOA1—Behcet's disease	6.37e-05	0.000207	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—NOS3—Behcet's disease	6.35e-05	0.000206	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—NOS3—Behcet's disease	6.35e-05	0.000206	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—CAT—Behcet's disease	6.34e-05	0.000206	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—SERPINE1—Behcet's disease	6.31e-05	0.000205	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—SERPINE1—Behcet's disease	6.3e-05	0.000204	CbGpPWpGaD
Sorafenib—HTR2C—Signaling by GPCR—CXCL8—Behcet's disease	6.26e-05	0.000203	CbGpPWpGaD
Sorafenib—MAPK11—Signaling Pathways—CXCL8—Behcet's disease	6.25e-05	0.000203	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—CAT—Behcet's disease	6.2e-05	0.000201	CbGpPWpGaD
Sorafenib—BRAF—Signaling Pathways—CXCL8—Behcet's disease	6.19e-05	0.000201	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—APOB—Behcet's disease	6.15e-05	0.0002	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—NOS3—Behcet's disease	6.03e-05	0.000196	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—APOB—Behcet's disease	6.02e-05	0.000195	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—NOS3—Behcet's disease	6.01e-05	0.000195	CbGpPWpGaD
Sorafenib—UGT1A1—Metabolism—NOS3—Behcet's disease	5.93e-05	0.000193	CbGpPWpGaD
Sorafenib—UGT1A9—Metabolism—NOS3—Behcet's disease	5.93e-05	0.000193	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—SERPINE1—Behcet's disease	5.67e-05	0.000184	CbGpPWpGaD
Sorafenib—KIT—Signaling Pathways—CXCL8—Behcet's disease	5.63e-05	0.000183	CbGpPWpGaD
Sorafenib—MAP3K7—Signaling Pathways—CXCL8—Behcet's disease	5.63e-05	0.000183	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—APOA1—Behcet's disease	5.5e-05	0.000178	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—NOS3—Behcet's disease	5.41e-05	0.000176	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—SERPINE1—Behcet's disease	5.41e-05	0.000176	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—CAT—Behcet's disease	5.37e-05	0.000174	CbGpPWpGaD
Sorafenib—FGFR1—Signaling Pathways—CXCL8—Behcet's disease	5.35e-05	0.000173	CbGpPWpGaD
Sorafenib—PDGFRA—Signaling Pathways—CXCL8—Behcet's disease	5.33e-05	0.000173	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—APOB—Behcet's disease	5.21e-05	0.000169	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—NOS3—Behcet's disease	5.16e-05	0.000168	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—SERPINE1—Behcet's disease	5.06e-05	0.000164	CbGpPWpGaD
Sorafenib—ABCG2—Metabolism—NOS3—Behcet's disease	5.03e-05	0.000163	CbGpPWpGaD
Sorafenib—CYP3A7—Metabolism—NOS3—Behcet's disease	4.99e-05	0.000162	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—APOA1—Behcet's disease	4.87e-05	0.000158	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—NOS3—Behcet's disease	4.83e-05	0.000157	CbGpPWpGaD
Sorafenib—PDGFRB—Signaling Pathways—CXCL8—Behcet's disease	4.8e-05	0.000156	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—CAT—Behcet's disease	4.79e-05	0.000155	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—APOA1—Behcet's disease	4.76e-05	0.000154	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—CAT—Behcet's disease	4.68e-05	0.000152	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—APOB—Behcet's disease	4.65e-05	0.000151	CbGpPWpGaD
Sorafenib—HTR2B—Signaling Pathways—CXCL8—Behcet's disease	4.58e-05	0.000149	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—APOB—Behcet's disease	4.54e-05	0.000147	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—CAT—Behcet's disease	4.41e-05	0.000143	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—CAT—Behcet's disease	4.37e-05	0.000142	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—SERPINE1—Behcet's disease	4.36e-05	0.000142	CbGpPWpGaD
Sorafenib—RAF1—Signaling Pathways—CXCL8—Behcet's disease	4.28e-05	0.000139	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—APOB—Behcet's disease	4.28e-05	0.000139	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—APOB—Behcet's disease	4.24e-05	0.000138	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—NOS3—Behcet's disease	4.17e-05	0.000135	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—APOA1—Behcet's disease	4.12e-05	0.000134	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—CAT—Behcet's disease	3.73e-05	0.000121	CbGpPWpGaD
Sorafenib—HTR2C—Signaling Pathways—CXCL8—Behcet's disease	3.7e-05	0.00012	CbGpPWpGaD
Sorafenib—CYP2B6—Metabolism—NOS3—Behcet's disease	3.69e-05	0.00012	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—APOA1—Behcet's disease	3.68e-05	0.000119	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—APOB—Behcet's disease	3.62e-05	0.000118	CbGpPWpGaD
Sorafenib—CYP3A5—Metabolism—NOS3—Behcet's disease	3.61e-05	0.000117	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—APOA1—Behcet's disease	3.59e-05	0.000117	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—APOA1—Behcet's disease	3.38e-05	0.00011	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—APOA1—Behcet's disease	3.36e-05	0.000109	CbGpPWpGaD
Sorafenib—CYP2C8—Metabolism—NOS3—Behcet's disease	3.12e-05	0.000101	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—CAT—Behcet's disease	2.88e-05	9.35e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—APOA1—Behcet's disease	2.87e-05	9.3e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—APOB—Behcet's disease	2.8e-05	9.08e-05	CbGpPWpGaD
Sorafenib—CYP2C19—Metabolism—NOS3—Behcet's disease	2.79e-05	9.05e-05	CbGpPWpGaD
Sorafenib—ABCB1—Metabolism—NOS3—Behcet's disease	2.72e-05	8.83e-05	CbGpPWpGaD
Sorafenib—CYP2D6—Metabolism—NOS3—Behcet's disease	2.56e-05	8.32e-05	CbGpPWpGaD
Sorafenib—CYP2C9—Metabolism—NOS3—Behcet's disease	2.54e-05	8.25e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—APOA1—Behcet's disease	2.21e-05	7.18e-05	CbGpPWpGaD
Sorafenib—CYP1A2—Metabolism—NOS3—Behcet's disease	2.17e-05	7.05e-05	CbGpPWpGaD
Sorafenib—CYP3A4—Metabolism—NOS3—Behcet's disease	1.68e-05	5.44e-05	CbGpPWpGaD
